KOREA PHARMA Co., Ltd. 032300.KQ Stock
KOREA PHARMA Co., Ltd. Price Chart
KOREA PHARMA Co., Ltd. 032300.KQ Financial and Trading Overview
KOREA PHARMA Co., Ltd. stock price | 19890 KRW |
Previous Close | 19510 KRW |
Open | 19610 KRW |
Bid | 19660 KRW x N/A |
Ask | 19670 KRW x N/A |
Day's Range | 19430 - 19710 KRW |
52 Week Range | 19280 - 44000 KRW |
Volume | 8.77K KRW |
Avg. Volume | 30.92K KRW |
Market Cap | N/A |
Beta (5Y Monthly) | 1.683363 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
032300.KQ Valuation Measures
Enterprise Value | 221.86B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 2.722 |
Enterprise Value/EBITDA | 25.839 |
Trading Information
KOREA PHARMA Co., Ltd. Stock Price History
Beta (5Y Monthly) | 1.683363 |
52-Week Change | -22.57% |
S&P500 52-Week Change | 20.43% |
52 Week High | 44000 KRW |
52 Week Low | 19280 KRW |
50-Day Moving Average | 20306.4 KRW |
200-Day Moving Average | 22486.85 KRW |
032300.KQ Share Statistics
Avg. Volume (3 month) | 30.92K KRW |
Avg. Daily Volume (10-Days) | 14.54K KRW |
Shares Outstanding | N/A |
Float | 3.63M |
Short Ratio | N/A |
% Held by Insiders | 65.29% |
% Held by Institutions | 0.20% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | September 30, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | 4.35% |
Operating Margin (ttm) | 7.51% |
Gross Margin | 43.34% |
EBITDA Margin | 10.53% |
Management Effectiveness
Return on Assets (ttm) | 3.61% |
Return on Equity (ttm) | 6.45% |
Income Statement
Revenue (ttm) | 81.51B KRW |
Revenue Per Share (ttm) | 7470.35 KRW |
Quarterly Revenue Growth (yoy) | 6.00% |
Gross Profit (ttm) | 35.9B KRW |
EBITDA | 8.59B KRW |
Net Income Avi to Common (ttm) | 3.55B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | -55.90% |
Balance Sheet
Total Cash (mrq) | 63.49B KRW |
Total Cash Per Share (mrq) | 5821.01 KRW |
Total Debt (mrq) | 53.03B KRW |
Total Debt/Equity (mrq) | 89.97 KRW |
Current Ratio (mrq) | 4.348 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 9.86B KRW |
Levered Free Cash Flow (ttm) | 1.62B KRW |
Profile of KOREA PHARMA Co., Ltd.
Country | South Korea |
State | N/A |
City | Seoul |
Address | 14, Teheran-ro 4-gil |
ZIP | 445 922 |
Phone | 82 558 1277 |
Website | https://www.koreapharma.co.kr |
Industry | |
Sector(s) | |
Full Time Employees | N/A |
Korea Pharmacy Co., Ltd. produces pharmaceutical drugs. It offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, and specialty drugs, as well as multivitamins, skeltal muscle relaxants, vitamin B1, etc. The company was founded in 1974 and is based in Seoul, South Korea.
Q&A For KOREA PHARMA Co., Ltd. Stock
What is a current 032300.KQ stock price?
KOREA PHARMA Co., Ltd. 032300.KQ stock price today per share is 19890 KRW.
How to purchase KOREA PHARMA Co., Ltd. stock?
You can buy 032300.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for KOREA PHARMA Co., Ltd.?
The stock symbol or ticker of KOREA PHARMA Co., Ltd. is 032300.KQ.
How many shares does KOREA PHARMA Co., Ltd. have in circulation?
The max supply of KOREA PHARMA Co., Ltd. shares is 10.91M.
What is KOREA PHARMA Co., Ltd. Price to Earnings Ratio (PE Ratio)?
KOREA PHARMA Co., Ltd. PE Ratio is now.
What was KOREA PHARMA Co., Ltd. earnings per share over the trailing 12 months (TTM)?
KOREA PHARMA Co., Ltd. EPS is 0 KRW over the trailing 12 months.